Coloplast A/S banner

Coloplast A/S
CSE:COLO B

Watchlist Manager
Coloplast A/S Logo
Coloplast A/S
CSE:COLO B
Watchlist
Price: 492.1 DKK 0.63%
Market Cap: kr110.7B

Gross Margin

67.9%
Current
Improving
by 0.4%
vs 3-y average of 67.4%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
67.9%
=
Gross Profit
kr18.9B
/
Revenue
kr27.9B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
67.9%
=
Gross Profit
kr18.9B
/
Revenue
kr27.9B

Peer Comparison

Country Company Market Cap Gross
Margin
DK
Coloplast A/S
CSE:COLO B
110.7B DKK
Loading...
JP
Hoya Corp
TSE:7741
9.6T JPY
Loading...
US
Medline Inc
NASDAQ:MDLN
59.5B USD
Loading...
CH
Alcon AG
SIX:ALC
30.3B CHF
Loading...
US
Align Technology Inc
NASDAQ:ALGN
14.2B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
41.5B CNY
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.1B CHF
Loading...
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.8B USD
Loading...
KR
HLB Inc
KOSDAQ:028300
6.9T KRW
Loading...

Market Distribution

Higher than 72% of companies in Denmark
Percentile
72st
Based on 447 companies
72st percentile
67.9%
Low
-2 199.8% — 26.7%
Typical Range
26.7% — 65.9%
High
65.9% — 1 637.7%
Distribution Statistics
Denmark
Min -2 199.8%
30th Percentile 26.7%
Median 45.7%
70th Percentile 65.9%
Max 1 637.7%

Coloplast A/S
Glance View

Coloplast A/S, headquartered in Humlebæk, Denmark, has a storied history that dates back to 1954 when a nurse, Elise Sørensen, identified a crucial need in the healthcare sector. Her sister had undergone ostomy surgery, and the lack of appropriate post-operative care products inspired Sørensen to design the world’s first adhesive ostomy bag. This innovation laid the groundwork for Coloplast's trajectory in the healthcare industry. Today, the company has expanded its focus to include ostomy care, continence care, wound and skin care, and interventional urology. With a commitment to improving patients' quality of life, Coloplast has become a leader in designing and manufacturing products that not only highlight practicality but also embody comfort and discretion. Coloplast generates revenue through a business model that emphasizes product innovation and direct engagement with healthcare providers and patients. The company invests significantly in research and development to improve and widen its product offerings continuously. It operates globally, distributing its products directly and via partnerships with hospitals, clinics, and healthcare professionals. By maintaining an attentive approach to user experience and incorporating customer feedback into its development processes, Coloplast ensures its portfolio aligns with the actual needs of its users. This user-centered strategy not only enhances customer loyalty but also fortifies the company’s market position, driving its financial success.

COLO B Intrinsic Value
632.18 DKK
Undervaluation 22%
Intrinsic Value
Price
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
67.9%
=
Gross Profit
kr18.9B
/
Revenue
kr27.9B
What is Coloplast A/S's current Gross Margin?

The current Gross Margin for Coloplast A/S is 67.9%, which is above its 3-year median of 67.4%.

How has Gross Margin changed over time?

Over the last 3 years, Coloplast A/S’s Gross Margin has decreased from 68.7% to 67.9%. During this period, it reached a low of 66.6% on Sep 30, 2023 and a high of 68.7% on Dec 31, 2022.

Back to Top